Home Healthcare Biotechnology Chemiluminescence Immunoassay Market

Chemiluminescence Immunoassay Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Software & Services), By Sample Type (Blood, Urine, Saliva, Others), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Others), By End User (Hospitals and Clinics, Medical and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR1240DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Chemiluminescence Immunoassay Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Instruments
      1. Automated
      2. Semi-automated
    2. Consumables
    3. Software & Services
  2. Chemiluminescence Immunoassay Market, By Sample Type 2022-2034 (USD MILLION/ Units)
    1. Blood
    2. Urine
    3. Saliva
    4. Others
  3. Chemiluminescence Immunoassay Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Therapeutic Drug Monitoring
    2. Oncology
    3. Cardiology
    4. Endocrinology
    5. Infectious Disease
    6. Autoimmune Disease
    7. Others
  4. Chemiluminescence Immunoassay Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Medical and Diagnostic Laboratories
    3. Pharmaceutical and Biotechnology Companies
    4. Others
  5. Regional Chemiluminescence Immunoassay Market
    1. North America
      1. North America Chemiluminescence Immunoassay Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
      2. North America Chemiluminescence Immunoassay Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Blood
        2. Urine
        3. Saliva
        4. Others
      3. North America Chemiluminescence Immunoassay Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic Drug Monitoring
        2. Oncology
        3. Cardiology
        4. Endocrinology
        5. Infectious Disease
        6. Autoimmune Disease
        7. Others
      4. North America Chemiluminescence Immunoassay Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Medical and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies
        4. Others
      5. U.S.
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      6. Canada
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
    2. Europe
      1. Europe Chemiluminescence Immunoassay Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
      2. Europe Chemiluminescence Immunoassay Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Blood
        2. Urine
        3. Saliva
        4. Others
      3. Europe Chemiluminescence Immunoassay Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic Drug Monitoring
        2. Oncology
        3. Cardiology
        4. Endocrinology
        5. Infectious Disease
        6. Autoimmune Disease
        7. Others
      4. Europe Chemiluminescence Immunoassay Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Medical and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies
        4. Others
      5. U.K.
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      6. Germany
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      7. France
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      8. Spain
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      9. Italy
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      10. Russia
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      11. Nordic
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      12. Benelux
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      13. Rest of Europe
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
    3. APAC
      1. APAC Chemiluminescence Immunoassay Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
      2. APAC Chemiluminescence Immunoassay Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Blood
        2. Urine
        3. Saliva
        4. Others
      3. APAC Chemiluminescence Immunoassay Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic Drug Monitoring
        2. Oncology
        3. Cardiology
        4. Endocrinology
        5. Infectious Disease
        6. Autoimmune Disease
        7. Others
      4. APAC Chemiluminescence Immunoassay Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Medical and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies
        4. Others
      5. China
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      6. Korea
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      7. Japan
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      8. India
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      9. Australia
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      10. Taiwan
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      11. South East Asia
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      12. Rest of Asia-Pacific
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
    4. Middle East and Africa
      1. Middle East and Africa Chemiluminescence Immunoassay Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
      2. Middle East and Africa Chemiluminescence Immunoassay Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Blood
        2. Urine
        3. Saliva
        4. Others
      3. Middle East and Africa Chemiluminescence Immunoassay Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic Drug Monitoring
        2. Oncology
        3. Cardiology
        4. Endocrinology
        5. Infectious Disease
        6. Autoimmune Disease
        7. Others
      4. Middle East and Africa Chemiluminescence Immunoassay Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Medical and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies
        4. Others
      5. UAE
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      6. Turkey
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      7. Saudi Arabia
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      8. South Africa
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      9. Egypt
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      10. Nigeria
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      11. Rest of MEA
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
    5. LATAM
      1. LATAM Chemiluminescence Immunoassay Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
      2. LATAM Chemiluminescence Immunoassay Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Blood
        2. Urine
        3. Saliva
        4. Others
      3. LATAM Chemiluminescence Immunoassay Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic Drug Monitoring
        2. Oncology
        3. Cardiology
        4. Endocrinology
        5. Infectious Disease
        6. Autoimmune Disease
        7. Others
      4. LATAM Chemiluminescence Immunoassay Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Medical and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies
        4. Others
      5. Brazil
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      6. Mexico
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      7. Argentina
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      8. Chile
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      9. Colombia
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
      10. Rest of LATAM
        1. Instruments
          1. Automated
          2. Semi-automated
        2. Consumables
        3. Software & Services
        4. Blood
        5. Urine
        6. Saliva
        7. Others
        8. Therapeutic Drug Monitoring
        9. Oncology
        10. Cardiology
        11. Endocrinology
        12. Infectious Disease
        13. Autoimmune Disease
        14. Others
        15. Hospitals and Clinics
        16. Medical and Diagnostic Laboratories
        17. Pharmaceutical and Biotechnology Companies
        18. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.